SKYE BIOSCIENCE INC (SKYE) Stock Income Statement
NASDAQ:SKYE - Nasdaq - US83086J2006 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 42.03M | 36.43M | 34.89M | 12.11M | 7.85M | |||
| Research and Development | 23.95M | 18.70M | 27.03M | 6.01M | 2.93M | |||
| Selling, General, and Administrative Expenses | 18.08M | 17.73M | 7.85M | 6.09M | 4.92M | |||
| Operating Income | -42.03M | -36.43M | -34.89M | -12.11M | -7.85M | |||
| Interest Income/Expense | 2.95M | 2.28M | -806.30K | -710.00K | -790.00K | |||
| Other Income/Expense | N/A | 0.00 | -1.38M | N/A | N/A | |||
| Non Recurring Items | N/A | 6.23M | -257.50K | -6.66M | 120.00K | |||
| Income Before Taxes | -32.64M | -26.56M | -37.64M | -19.47M | -8.52M | |||
| Income Tax | 10.10K | 10.10K | 3.60K | 10.00K | 0.00 | |||
| Net Income | -32.65M | -26.57M | -37.64M | -19.48M | -8.52M | |||
| EBITDA | -41.59M | -36.13M | -34.76M | -11.99M | -7.82M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.83 | -0.73 | -5.37 | -8.77 | -5.24 | |||
| Non GAAP EPS | -0.82 | -0.72 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD